Answers are grounded in this paper and cite their sources.
Objective: The objective of this study was to summarize clinical experience in the diagnosis and treatment of cutaneous anthrax, improve early recognition and standardized management, and reduce misdiagnosis and the occurrence of severe disease. Methods: We retrospectively reviewed the clinical data of five patients with confirmed cutaneous anthrax admitted to Beijing Ditan Hospital, Capital Medical University, between December 2023 and May 2026, and summarized the diagnosis, treatment, and clinical characteristics of the disease. Results: All patients were male and had agricultural exposure. The typical clinical presentation consisted of painless papules and vesicles progressing to ulceration, crusting, and a black eschar. Some patients had fever, and laboratory testing showed elevated white blood cell counts and C-reactive protein levels. All patients were diagnosed with cutaneous anthrax by etiologic testing; among them, one patient developed anthrax meningitis and another developed septicemia. After standardized antimicrobial therapy with susceptible agents including meropenem, clindamycin, levofloxacin, and doxycycline, combined with local wound care and supportive treatment, all five patients recovered and were discharged. No deaths occurred, and no recurrence or sequelae were observed during follow-up. Conclusions: Cutaneous anthrax can be diagnosed early by combining epidemiologic history, typical skin lesions, and etiologic testing. Prompt standardized antimicrobial therapy and appropriate wound care are key to improving patient outcomes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: